Ozkan, B., Orhan, E., Aktas, N
Consult a healthcare provider: Always speak with a doctor before making any changes, as high B12 levels may be linked to underlying health conditions that need proper evaluation and management
While SSRIs are efficacious, their safety profile in terms of reproductive system toxicity remains controversial, especially in developing adolescents, fertile adults, and perinatal pregnant women ( 2 Effects of SSRIs on reproductive cytogenesis 2.1 Effects of SSRIs on male germ cells Several studies have found that fluoxetine disrupts the hypothalamuslobetestis axis, significantly decreasing the serum concentrations of luteinizing hormone (LH), follicle stimulating hormone (FSH), progesterone, and testosterone, while also affecting several sperm quality parameters, as evidenced by decreased sperm concentrations and viability, increased deoxyribonucleic acid (DNA) fragmentation, and lower reproductive organ weights (Figure 1), which could have been attributed to diminished androgen levels
Regarding cagrilintide dosage with retatrutide : Clinical Practice Considerations: Ensure medical director oversight for any peptide therapy protocols Develop comprehensive informed consent documents addressing experimental nature of novel combinations Implement robust adverse event monitoring and reporting systems Maintain current knowledge of regulatory developments Consider liability implications of off-label combination therapies Establish clear referral pathways to endocrinology or obesity medicine specialists Patient Education Materials: Creating clear, accurate educational resources about cagrilintide, retatrutide, and the absence of combination data serves patient safety and informed decision-making
Cartea ME, Francisco M, Soengas P, Velasco P
